School of Health and Related Research, University of Sheffield, Sheffield, England.
Reproductive Health and Family Planning, MoHS, Freetown, Sierra Leone.
Reprod Health. 2023 Jan 6;20(1):6. doi: 10.1186/s12978-022-01551-2.
The CRADLE (Community blood pressure monitoring in Rural Africa: Detection of underLying pre-Eclampsia) Vital Signs Alert device-designed specifically to improve maternity care in low resource settings-had varying impact when trialled in different countries. To better understand the contextual factors that may contribute to this variation, this study retrospectively evaluated the adoption of CRADLE, during scale-up in Sierra Leone.
This was a mixed methods study. A quantitative indicator of adoption (the proportion of facilities trained per district) was calculated from existing training records, then focus groups were held with 'CRADLE Champions' in each district (n = 32), to explore adoption qualitatively. Template Analysis was used to deductively interpret qualitative data, guided by the NASSS (non-adoption, abandonment, scale-up, spread, sustainability) Framework.
Substantial but non-significant variation was found in the proportion of facilities trained in each district (range 59-90%) [X (7, N = 8) = 10.419, p = 0.166]. Qualitative data identified complexity in two NASSS domains that may have contributed to this variation: 'the technology' (for example, charging issues, difficulty interpreting device output and concerns about ongoing procurement) and 'the organisation' (for example, logistical barriers to implementing training, infighting and high staff turnover). Key strategies mentioned to mitigate against these issues included: transparent communication at all levels; encouraging localised adaptations during implementation (including the involvement of community leaders); and selecting Champions with strong soft skills (particularly conflict resolution and problem solving).
Complexity related to the technology and the organisational context were found to influence the adoption of CRADLE in Sierra Leone, with substantial inter-district variation. These findings emphasise the importance of gaining an in-depth understanding of the specific system and context in which a new healthcare technology is being implemented. This study has implications for the ongoing scale-up of CRADLE, and for those implementing or evaluating other health technologies in similar contexts.
CRADLE(社区在非洲农村地区的血压监测:检测潜在的子痫前期)生命体征警示器是专门为改善资源匮乏环境下的产妇护理而设计的,它在不同国家的试验中产生了不同的影响。为了更好地了解可能导致这种差异的背景因素,本研究回顾性评估了 CRADLE 在塞拉利昂扩大规模期间的采用情况。
这是一项混合方法研究。从现有培训记录中计算出采用的定量指标(每个地区接受培训的设施比例),然后在每个地区与“CRADLE 冠军”举行焦点小组(n=32),从定性角度探讨采用情况。模板分析用于根据 NASSS(不采用、放弃、扩大、传播、可持续性)框架对定性数据进行演绎解释。
每个地区接受培训的设施比例存在显著但无统计学意义的差异(范围 59-90%)[X(7,N=8)=10.419,p=0.166]。定性数据确定了可能导致这种差异的两个 NASSS 领域的复杂性:“技术”(例如,收费问题、解读设备输出困难和对持续采购的担忧)和“组织”(例如,实施培训的后勤障碍、内斗和高员工流失率)。提到的减轻这些问题的关键策略包括:在各个层面进行透明沟通;在实施过程中鼓励本地化适应(包括社区领导人的参与);选择具有强大软技能的冠军(特别是解决冲突和解决问题的能力)。
发现与技术和组织背景相关的复杂性会影响 CRADLE 在塞拉利昂的采用,地区间存在很大差异。这些发现强调了在实施新的医疗技术时深入了解特定系统和背景的重要性。本研究对 CRADLE 的持续扩大规模以及在类似背景下实施或评估其他医疗技术具有启示意义。